Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L Rutishauser

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Early immune responses anticipate HIV rebound and precede viral controlAnna Farrell-Sherman, Walker Azam, Natalia de la Force, et al.
JCI Insight|December 22, 2020
TCF-1 regulates HIV-specific CD8+ T cell expansion capacityRachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19Michael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Cell Reports|August 6, 2021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Immunity|January 30, 2026
Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammationMiqdad O Dhariwala, Ricardo O Carale, Andrea M DeRogatis, et al.
JCI Insight|March 10, 2025
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infectionsMiguel A Garcia-Knight, J Daniel Kelly, Scott Lu, et al.
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Nature|March 19, 2026
In vivo site-specific engineering to reprogram T cellsWilliam A Nyberg, Pierre-Louis Bernard, Wayne Ngo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|June 12, 2026
Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention controlJulia A Wagner, Demi A Sandel, Ravi K Patel, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Early immune responses anticipate HIV rebound and precede viral controlAnna Farrell-Sherman, Walker Azam, Natalia de la Force, et al.
JCI Insight|December 22, 2020
TCF-1 regulates HIV-specific CD8+ T cell expansion capacityRachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19Michael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Cell Reports|August 6, 2021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J Peluso, Amelia N Deitchman, Leonel Torres, et al.
Immunity|January 30, 2026
Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammationMiqdad O Dhariwala, Ricardo O Carale, Andrea M DeRogatis, et al.
JCI Insight|March 10, 2025
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infectionsMiguel A Garcia-Knight, J Daniel Kelly, Scott Lu, et al.
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Nature|March 19, 2026
In vivo site-specific engineering to reprogram T cellsWilliam A Nyberg, Pierre-Louis Bernard, Wayne Ngo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Pageof 5